real-world data on the safety of emicizumab in patients with hemophilia a
Published 1 year ago • 88 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
0:32
the importance of obtaining real-world data
-
6:31
the importance of patient perspectives and real-world data
-
3:56
real world data for cll management
-
7:09
the role of real-world evidence in the evaluation of new drugs
-
3:48
real world evidence: what is it and what can it tell us?
-
1:43
real-world outcomes of teclistamab for r/r multiple myeloma
-
2:43
collecting real world data from novel treatments
-
1:33
teclistamab for multiple myeloma in us hospitals: real-world data analysis
-
1:59
real-world outcomes of ide-cel in heavily pre-treated r/r mm
-
3:52
real-world data on outcomes of t(11;14) multiple myeloma
-
2:34
real-world data and mrd in cll
-
8:34
hct in mds: cell source and conditioning type
-
2:53
real-world data on upfront subcutaneous bortezomib-containing regimens for newly diagnosed myeloma
-
0:41
isct in bringing together the scientific community
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:00:51
head-to-head comparisons using real-world data
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:39
session highlights: the value of clinical hematology research groups